H.C. Wainwright launched its coverage of eczema drug developer Corvus Pharmaceuticals (NASDAQ:CRVS) with a Buy recommendation and an $11 per share target on Thursday, despite an over 38% drop ...

Robute Guilliman and Lion El’Jonson are the only two loyalist Primarchs around and they need some back-up from their brothers. There are currently two loyalist Primarchs in 40k that can take to the ...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) released interim data from a Phase 1 trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis. The trial will enroll 64 ...

What are the best Warhammer games? Games Workshop has a complicated history with licensing its tabletop worlds. There were some great Warhammer Fantasy strategy games back in the ’90s, but the ...

After hours: January 3 at 7:43:18 p.m. EST ...